134 related articles for article (PubMed ID: 30718665)
61. Identification of Cardiac Glycosides as Novel Inhibitors of eIF4A1-Mediated Translation in Triple-Negative Breast Cancer Cells.
Howard CM; Estrada M; Terrero D; Tiwari AK; Raman D
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32759815
[TBL] [Abstract][Full Text] [Related]
62. RNA helicase EIF4A1-mediated translation is essential for the GC response.
Screen M; Matheson LS; Howden AJ; Strathdee D; Willis AE; Bushell M; Sansom O; Turner M
Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 38011999
[TBL] [Abstract][Full Text] [Related]
63. Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents.
Low WK; Li J; Zhu M; Kommaraju SS; Shah-Mittal J; Hull K; Liu JO; Romo D
Bioorg Med Chem; 2014 Jan; 22(1):116-25. PubMed ID: 24359706
[TBL] [Abstract][Full Text] [Related]
64. Comparing the Effects of Rocaglates on Energy Metabolism and Immune Modulation on Cells of the Human Immune System.
Schiffmann S; Henke M; Seifert M; Ulshöfer T; Roser LA; Magari F; Wendel HG; Grünweller A; Parnham MJ
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982945
[TBL] [Abstract][Full Text] [Related]
65. Eukaryotic translation initiation factor 4A1 in the pathogenesis and treatment of cancers.
Huang J; Zhang L; Yang R; Yao L; Gou J; Cao D; Pan Z; Li D; Pan Y; Zhang W
Front Mol Biosci; 2023; 10():1289650. PubMed ID: 38028556
[TBL] [Abstract][Full Text] [Related]
66. eIF4A1 is a promising new therapeutic target in ER-negative breast cancer.
Stoneley M; Willis AE
Cell Death Differ; 2015 Apr; 22(4):524-5. PubMed ID: 25613380
[No Abstract] [Full Text] [Related]
67. Imidazole Derivative As a Novel Translation Inhibitor.
Lukianov DA; Buev VS; Ivanenkov YA; Kartsev VG; Skvortsov DA; Osterman IA; Sergiev PV
Acta Naturae; 2022; 14(2):71-77. PubMed ID: 35923569
[TBL] [Abstract][Full Text] [Related]
68. MYC inhibitors in multiple myeloma.
Martínez-Martín S; Soucek L
Cancer Drug Resist; 2021; 4(4):842-865. PubMed ID: 35582389
[TBL] [Abstract][Full Text] [Related]
69. Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers.
Xue C; Gu X; Li G; Bao Z; Li L
Front Cell Dev Biol; 2021; 9():711965. PubMed ID: 34869305
[TBL] [Abstract][Full Text] [Related]
70. A forward genetic screen identifies modifiers of rocaglate responsiveness.
Shen L; Pugsley L; Cencic R; Wang H; Robert F; Naineni SK; Sahni A; Morin G; Zhang W; Nijnik A; Porco JA; Langlais D; Huang S; Pelletier J
Sci Rep; 2021 Sep; 11(1):18516. PubMed ID: 34531456
[TBL] [Abstract][Full Text] [Related]
71. Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from
Greger H
Phytochem Rev; 2022; 21(3):725-764. PubMed ID: 34104125
[TBL] [Abstract][Full Text] [Related]
72. Intercepted Retro-Nazarov Reaction: Syntheses of Amidino-Rocaglate Derivatives and Their Biological Evaluation as eIF4A Inhibitors.
Zhang W; Chu J; Cyr AM; Yueh H; Brown LE; Wang TT; Pelletier J; Porco JA
J Am Chem Soc; 2019 Aug; 141(32):12891-12900. PubMed ID: 31310112
[TBL] [Abstract][Full Text] [Related]
73. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.
Bordeleau ME; Robert F; Gerard B; Lindqvist L; Chen SM; Wendel HG; Brem B; Greger H; Lowe SW; Porco JA; Pelletier J
J Clin Invest; 2008 Jul; 118(7):2651-60. PubMed ID: 18551192
[TBL] [Abstract][Full Text] [Related]
74. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
[TBL] [Abstract][Full Text] [Related]
75. A comparative study of small molecules targeting eIF4A.
Naineni SK; Itoua Maïga R; Cencic R; Putnam AA; Amador LA; Rodriguez AD; Jankowsky E; Pelletier J
RNA; 2020 May; 26(5):541-549. PubMed ID: 32014999
[TBL] [Abstract][Full Text] [Related]
76. Targeting the eIF4A RNA helicase as an anti-neoplastic approach.
Chu J; Pelletier J
Biochim Biophys Acta; 2015 Jul; 1849(7):781-91. PubMed ID: 25234619
[TBL] [Abstract][Full Text] [Related]
77. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
Shen L; Pelletier J
Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
[TBL] [Abstract][Full Text] [Related]
78. Oxo-aglaiastatin-Mediated Inhibition of Translation Initiation.
Itoua Maïga R; Cencic R; Chu J; Waller DD; Brown LE; Devine WG; Zhang W; Sebag M; Porco JA; Pelletier J
Sci Rep; 2019 Feb; 9(1):1265. PubMed ID: 30718665
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
